Literature DB >> 27923452

MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.

Akiko Matsuda1, Irene K Yan1, Catherine Foye1, Mansi Parasramka1, Tushar Patel2.   

Abstract

The contribution of microRNAs to the regulation of mRNA expression during physiological and developmental processes are well-recognized. These roles are being expanded by recent observations that emphasize the capability of miRNA to participate in inter-cellular signaling and communication. Several factors support a functional role for miRNA as mediators of cell-to-cell signaling. miRNA are able to exist within the extracellular milieu or circulation, and their stability and integrity maintained through association with binding proteins or lipoproteins, or through encapsulation within cell-derived membrane vesicles. Furthermore, miRNA can retain functionality and regulate target gene expression following their uptake by recipient cells. In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabolic diseases and cancers. Elucidating the mechanisms involved in inter-cellular communication involving miRNA will provide new insights into disease pathogenesis and potential therapeutic opportunities. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer microenvironment; cell–cell communication; extracellular vesicles; metabolic disorders; miRNAs

Mesh:

Substances:

Year:  2016        PMID: 27923452      PMCID: PMC5147504          DOI: 10.1016/j.beem.2016.07.005

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  96 in total

1.  Cancer cells use exosomes as tools to manipulate immunity and the microenvironment.

Authors:  Aled Clayton
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

2.  Dormancy of mammary carcinoma after mastectomy.

Authors:  T G Karrison; D J Ferguson; P Meier
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

Review 3.  ESCRT & Co.

Authors:  Ingrid Roxrud; Harald Stenmark; Lene Malerød
Journal:  Biol Cell       Date:  2010-03-12       Impact factor: 4.458

4.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

5.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

6.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

7.  Exosomes: secreted vesicles and intercellular communications.

Authors:  Clotilde Théry
Journal:  F1000 Biol Rep       Date:  2011-07-01

8.  Exosomal miRNAs: Biological Properties and Therapeutic Potential.

Authors:  Guoku Hu; Kristen M Drescher; Xian-Ming Chen
Journal:  Front Genet       Date:  2012-04-20       Impact factor: 4.599

9.  Propofol exerts anti-hepatocellular carcinoma by microvesicle-mediated transfer of miR-142-3p from macrophage to cancer cells.

Authors:  Jian Zhang; Wei-feng Shan; Te-te Jin; Guo-qing Wu; Xiao-Xing Xiong; Hai-yan Jin; Sheng-mei Zhu
Journal:  J Transl Med       Date:  2014-10-09       Impact factor: 5.531

10.  Circulating microRNA-126 in patients with coronary artery disease: correlation with LDL cholesterol.

Authors:  Xiao Sun; Man Zhang; Akimasa Sanagawa; Chieko Mori; Shiori Ito; Soichiro Iwaki; Hiroki Satoh; Satoshi Fujii
Journal:  Thromb J       Date:  2012-08-28
View more
  5 in total

Review 1.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

2.  Relationship between miR-21 and miR-182 levels in peripheral blood and gastric cancer tissue.

Authors:  Xiaodong Wang; Ran Wang; Fenghuan Li; Yuan Wu; Yu Liu; Wenfang Zhang
Journal:  Oncol Lett       Date:  2017-05-30       Impact factor: 2.967

3.  Integrated microRNA and mRNA expression profiling reveals a complex network regulating pomegranate (Punica granatum L.) seed hardness.

Authors:  Xiang Luo; Da Cao; Jianfeng Zhang; Li Chen; Xiaocong Xia; Haoxian Li; Diguang Zhao; Fuhong Zhang; Hui Xue; Lina Chen; Yongzhou Li; Shangyin Cao
Journal:  Sci Rep       Date:  2018-06-18       Impact factor: 4.379

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Polychlorinated Biphenyl Coexposure Alters the Expression Profile of MicroRNAs in the Liver Associated with Atherosclerosis.

Authors:  Qiuli Shan; Fan Qu; Ningning Chen
Journal:  Biomed Res Int       Date:  2020-08-12       Impact factor: 3.411

5.  Aging and aging-associated diseases: a microRNA-based endocrine regulation hypothesis.

Authors:  Samuil Umansky
Journal:  Aging (Albany NY)       Date:  2018-10-29       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.